Biomarker-Guided Therapy for Chronic Heart Failure
Author:
Berezin Alexander E.
Publisher
Springer Netherlands
Reference81 articles.
1. Adamopoulos C, Meyer P, Desai RV, et al. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail. 2011;13:200–6.
2. Adams Jr KF, Felker GM, Fraij G, et al. Biomarker guided therapy for heart failure: focus on natriuretic peptides. Heart Fail Rev. 2010;15(4):351–70.
3. Adlbrecht C, Huelsmann M, Berger R, et al. Cost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse care. Eur J Clin Invest. 2011;41(3):315–22.
4. Ahmad T, O’Connor CM. Therapeutic implications of biomarkers in chronic heart failure. Clin Pharmacol Ther. 2013;94(4):468–79.
5. Anand IS, Rector TS, Kuskowski M, et al. Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT. Eur J Heart Fail. 2013;15(5):511–8.